Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

I don’t “degrade” Anavex. I think the science has potential, and the question of efficacy of A2-73 and approvability should be played out. My issue with Anavex is senior management (Missling) and the board of directors (the people who have a fiduciary responsibility to prioritize shareholder value). We have a self-serving CEO with no credibility on Wall Street or pharma and a board of directors who are merely buddies of Missling.

I think shareholders would be better served by recruiting a reputable senior leadership team with a strong track record of success in drug development, regulatory approvals and commercialization, and a BOD that would put shareholder value first.

Being critical of the leadership of Anavex is not degrading Anavex the company, unless you consider Missling to be Anavex, which I do not.